Status:

RECRUITING

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

Lead Sponsor:

Institut Cancerologie de l'Ouest

Conditions:

Brain Metastases

MRI

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

About 20 to 30% of patients treated for cancer will have brain metastases. These brain metastases are found more frequently in patients with lung cancer, breast cancer or melanoma. The prognosis of th...

Eligibility Criteria

Inclusion

  • Primitive cancer (brest cancer, lung cancer, melanoma) proven histologically
  • Presence of brain metastasis visualized on MRI, of which at least one measures 5 mm
  • Age \> 18 years
  • Patient has valid health insurance
  • Written informed consent obtained from the patient prior to performing any protocol-related procedures, including screening evaluations

Exclusion

  • History of irradiation cerebral
  • History of brain surgery for brain metastasis or glial tumor
  • Systemic therapy (chemotherapy, targeted therapy, immunotherapy) modified in the 6 weeks preceding the realization of DOPA PET/CT,
  • New anti-tumor treatment started between the discovery of brain metastases and the performance of DOPA PET/CT
  • Other concomitant cancer, or history of cancer in the 5 years preceding the performance of DOPA PET/CT
  • Pregnant or lactating females
  • Persons deprived of their liberty, under a measure of safeguard of justice, under guardianship or placed under the authority of a guardian.
  • Disorder precluding understanding of trial information or informed consent.

Key Trial Info

Start Date :

December 3 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT04890028

Start Date

December 3 2021

End Date

February 1 2026

Last Update

August 17 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

CHU Angers

Angers, France, 49055

2

Institut de Cancerologie de l'Ouest

Angers, France, 49055

3

Institut de Cancerologie de L'Ouest

Saint-Herblain, France, 44055